AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants
AIT Therapeutics (OTC:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, today announced the allowance of its European Patent Application Number 13757959.5 entitled: “Inhalation of Nitric Oxide for Treating Respiratory Diseases.” The patent claims, …
AIT Therapeutics (OTC:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, today announced the allowance of its European Patent Application Number 13757959.5 entitled: “Inhalation of Nitric Oxide for Treating Respiratory Diseases.” The patent claims, directed towards the treatment of infants suffering from bronchiolitis with intermittent inhalation of at least 160ppm gaseous NO, are covered through March 7, 2033.
As quoted in the press release:
“We are pleased to continue to strengthen our intellectual property portfolio with the addition of this patent covering the delivery of NO at a concentration of at least 160ppm for infants with bronchiolitis,” said Steven Lisi, Chairman and Chief Executive Officer of AIT Therapeutics. “The patent covers use in the treatment of bacterial, viral, and/or fungal bronchiolitis, which includes RSV, the leading cause of bronchiolitis. Importantly, the patent also covers the intermittent delivery of NO, as precisely described in the protocol of our ongoing bronchiolitis (NO-BRO) trial. We continue to anticipate top-line data from the NO-BRO trial by the end of this quarter.”
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 1791.34 | +2.08 | |
Silver | 20.62 | -0.08 | |
Copper | 3.60 | +0.01 | |
Palladium | 2198.50 | -22.50 | |
Platinum | 941.00 | -3.00 | |
Oil | 91.67 | +0.91 | |
Heating Oil | 3.30 | +0.12 | |
Natural Gas | 7.69 | +0.10 |
DOWNLOAD FREE REPORTS
BROWSE COMPANIES BY SECTOR
- Agriculture Investing
- Phosphate Investing
- Potash Investing
- Base Metals Investing
- Copper Investing
- Iron Investing
- Lead Investing
- Nickel Investing
- Zinc Investing
- Battery Metals Investing
- Cobalt Investing
- Graphite Investing
- Lithium Investing
- Manganese Investing
- Vanadium Investing
- Critical Metals Investing
- Magnesium Investing
- Rare Earth Investing
- Scandium Investing
- Tantalum Investing
- Tellurium Investing
- Tungsten Investing
- Energy Investing
- Oil and Gas Investing
- Uranium Investing
- Gem Investing
- Diamond Investing
- Industrial Metals Investing
- Aluminum Investing
- Chromium Investing
- Coal Investing
- Molybdenum Investing
- Tin Investing
- Precious Metals Investing
- Gold Investing
- Palladium Investing
- Platinum Investing
- Silver Investing
- 3D Printing Investing
- Bitcoin Investing
- Blockchain Investing
- Cleantech Investing
- Cloud Investing
- Cryptocurrencies
- Data Investing
- Emerging Tech Investing
- Artificial Intelligence Investing
- Mobile Investing
- Robotics Investing
- Fintech Investing
- Gaming Investing
- Esports Investing
- Nanoscience Investing
- Graphene Investing
- Nanotech Investing
- Security Investing
Featured Medical Device Investing Stocks
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.